Making simple things complicated using anti-inflammatory reliever therapy. Issue 4 (29th April 2020)

• Record Type: Journal Article
• Authors: Lipworth, Brian; Kuo, Chris RuiWen; Chan, Rory
• Is Part Of: European respiratory journal. Volume 55:Issue 4(2020)
• Publication Date: 2020-04-29
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.00267-2020
• Languages: English
• ISSNs: 0903-1936

Abstract

We appreciated reading the eloquent editorial from Beasley et al . [1], who make a cogent evidence-based case for using budesonide/formoterol (BUD/FM) on demand ( p.r.n .) as the preferred asthma reliever, in keeping with the latest GINA guidelines. They proffer what appears at first sight to be a pragmatic stepwise treatment algorithm and associated action plan for using BUD/FM p.r.n . as anti-inflammatory reliever (AIR)±maintenance therapy across Global Initiative for Asthma steps 1 to 3. Use more budesonide/formoterol when you need it, and less when you don't http://bit.ly/2PKsCOH